Emergent Biosolutions Inc (EBS)
Healthcare
Drug Manufacturers - Specialty & Generic
7.40 $
+2.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Emergent Biosolutions Inc (EBS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.7% of the shares are freely tradable; institutional investors hold 86.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
86.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
3.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
95.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
20.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
52Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.41 | 4,341,462 | +2.0 | 03/31/2026 |
| State Street Corp | 5.52 | 2,849,701 | +5.7 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 5.34 | 2,757,158 | +22.4 | 03/31/2026 |
| American Century Companies Inc | 4.70 | 2,425,722 | -0.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.38 | 2,257,995 | +0.0 | 03/31/2026 |
| Charles Schwab Investment Management Inc | 2.92 | 1,506,075 | -7.0 | 03/31/2026 |
| Acadian Asset Management LLC | 2.68 | 1,381,624 | +411.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Avantis US Small Cap Value ETF | 4.95 | 2,556,372 | +0.1 | 07/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 3.25 | 1,675,960 | -1.0 | 07/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.01 | 1,554,116 | -3.4 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.